Weihang Bao
Weihang Bao publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Obesity, Physical Activity, Diet.
- World rank
- #198,547 of 7,710,434 ranked researchers
- Rank in United States
- #73,743 of 1,627,098
- Works
- 114
- Citations
- 17k
- Citations per work
- 151.6
What does Weihang Bao research?
Weihang Bao's work is mostly in Medicine (56%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6456.4%
- Medicine6456.4%
- Everything else5043.6%
- 1Cardiology and Cardiovascular Medicine13% of their works
- 2Surgery11% of their works
- 3Endocrinology, Diabetes and Metabolism11% of their works
- 4Public Health, Environmental and Occupational Health8% of their works
- 5Epidemiology7% of their works
- 6Pediatrics, Perinatology and Child Health6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Obesity, Physical Activity, Diet
- Birth, Development, and Health
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiovascular Health and Risk Factors
- Blood Pressure and Hypertension Studies
- Cancer, Lipids, and Metabolism
Which keywords describe Weihang Bao's research?
The keywords of their largest research topics: Obesity, Metabolic Syndrome, Cardiovascular Disease, C-Reactive Protein, Statins, Insulin Resistance, Cardiovascular Disease Prevention and Cholesterol.
- Lipid Metabolism
- Hypertension
- Ideal Cardiovascular Health
- Inflammation
- Fetal Programming
- Risk Factors
- Childhood
- Diabetes
- Epidemiology
- Cholesterol
- Insulin Resistance
- C-Reactive Protein
- Metabolic Syndrome
- Obesity
- Cardiovascular Disease
- Statins
- Cardiovascular Disease Prevention
- Cholesterol-lowering
- Public Health
- Glucose Metabolism
- Overweight
- Early-Life Conditions
- Adipose Tissue
- Cardiovascular Health
- Blood Pressure
- Fatty Acid Synthase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Obesity523 topics
- Metabolic Syndrome493 topics
- Cardiovascular Disease413 topics
- C-Reactive Protein402 topics
- Statins362 topics
- Insulin Resistance332 topics
- Cardiovascular Disease Prevention291 topic
- Cholesterol292 topics
- Cholesterol-lowering291 topic
- Epidemiology282 topics
- Public Health282 topics
- Diabetes221 topic
- Glucose Metabolism221 topic
- Childhood191 topic
- Overweight191 topic
- Risk Factors172 topics
- Early-Life Conditions161 topic
- Fetal Programming161 topic
- Adipose Tissue111 topic
- Inflammation111 topic
- Cardiovascular Health91 topic
- Ideal Cardiovascular Health91 topic
- Blood Pressure81 topic
- Hypertension81 topic
- Fatty Acid Synthase71 topic
- Lipid Metabolism71 topic
Where does Weihang Bao work?
Weihang Bao's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Weihang Bao have?
OpenAlex counts 114 works and 17,282 citations for Weihang Bao, an h-index of 44, ranking #198,547 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Weihang Bao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.